Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

A Kawaguchi1, K Miyatake, C Yutani

  • 1Department of Etiology and Pathophysiology, National Cardiovascular Center, Research Institute and Hospital, Osaka, Japan.

American Heart Journal
|February 27, 1999
PubMed

Insights

Familial hypercholesterolemia (FH) significantly impacts the aortic root and valve, leading to premature atherosclerosis. This "hypercholesterolemic valvulopathy" is particularly pronounced in homozygous FH patients, affecting aortic function.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Pathology

Background:

  • Familial hypercholesterolemia (FH) is known to affect coronary arteries.
  • Aortic valve dysfunction in homozygous FH patients suggests broader cardiovascular impact.
  • This study investigates aortic root and valve involvement in FH.

Purpose of the Study:

  • To characterize premature atherosclerotic lesions in the aortic root of patients with homozygous and heterozygous FH.
  • To assess aortic valve function and structure in FH patients.
  • To compare FH patients with normocholesterolemic controls.

Main Methods:

  • Histopathologic examination of aortic root specimens.
  • Cardiac catheterization and angiography in homozygous FH patients.
  • Color Doppler echocardiography in heterozygous FH patients and controls.
  • Measurement of aortic annulus diameter and aortic ridge dynamics.

Main Results:

  • 80% of homozygous FH patients showed aortic regurgitation; 30% had significant pressure gradients.
  • 80% of homozygous FH patients exhibited coronary ostia stenosis.
  • Aortic regurgitation was more prevalent in heterozygous FH patients (10/39) than controls (1/30).
  • Reduced aortic diameter and distensibility were observed in heterozygous FH patients.
  • Aortic valve cusp thickening and foam cell infiltration were noted in FH patients.

Conclusions:

  • Premature atherosclerosis in FH predominantly affects the aortic root.
  • Aortic valve involvement, termed "hypercholesterolemic valvulopathy," is a key feature of FH, especially homozygous forms.
  • Hypercholesterolemia's detrimental effects extend to the aortic valve, mirroring its impact on coronary arteries.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...